PANACEABIO.NS实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (6 May 2024 @ 17:59):

Panacea Biotec Limited, a biotechnology company, engages in the research and development, manufacture, and marketing of pharmaceuticals, vaccines, and biosimilars in India...

Stats
今日成交量	30 432.00
平均成交量	189 032
市值	8.49B
EPS	INR0 ( 2024-04-29 )
Last Dividend	INR0.750 ( 2011-09-19 )
Next Dividend	INR0 ( N/A )
P/E	-69.62
ATR14	INR0.181 (0.13%)

音量相关性

長: 0.08 (neutral)

短: 0.99 (very strong)

Signal:(42.181) Expect same movement, but be aware

Panacea Biotec Limited 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Panacea Biotec Limited 相关性 - 货币/商品

-0.12
( neutral )

-0.25
( neutral )

-0.55
( weak negative )

-0.57
( weak negative )

0.25
( neutral )

Panacea Biotec Limited 财务报表

Annual	2022
营收:	INR4.60B
毛利润:	INR2.07B (45.07 %)
EPS:	INR-5.51

FY	2022
营收:	INR4.60B
毛利润:	INR2.07B (45.07 %)
EPS:	INR-5.51

FY	2022
营收:	INR6.59B
毛利润:	INR3.59B (54.49 %)
EPS:	INR175.98

FY	2021
营收:	INR6.18B
毛利润:	INR3.89B (63.00 %)
EPS:	INR-24.11

Financial Reports:

No articles found.

Panacea Biotec Limited Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Panacea Biotec Limited Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 1.027 - No dividend growth expected in the near future

Information

First Dividend	INR1.000	2002-08-13
Last Dividend	INR0.750	2011-09-19
Next Dividend	INR0	N/A
Payout Date	2011-10-10
Next Payout Date	N/A
# dividends	9	--
Total Paid Out	INR8.50	--
Avg. Dividend % Per Year	0.00%	--
Score	0.73	--
Div. Sustainability Score	0
Div.Growth Potential Score	1.027
Div. Directional Score	0.463	--

Next Divdend (Est)
(2024-05-17)

INR0 Estimate 0.00 %

Dividend Stability

0.02 Very Bad

Dividend Score

0.73

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2002	INR0	0.00%
2003	INR0	0.00%
2004	INR0	0.00%
2005	INR0	0.00%
2006	INR0	0.00%
2007	INR0	0.00%
2008	INR0	0.00%
2009	INR0	0.00%
2010	INR0	0.00%
2011	INR0	0.00%
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR0	0.00%
2019	INR0	0.00%
2020	INR0	0.00%
2021	INR0	0.00%
2022	INR0	0.00%
2023	INR0	0.00%
2024	INR0	0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
RBLBANK.NS	Dividend Junior	2023-08-18	Sporadic	8	0.25%
KOVAI.NS	Dividend Junior	2023-08-10	Annually	4	0.17%
EXIDEIND.NS	Dividend Junior	2023-08-01	Annually	22	0.76%
AMIORG.NS	Dividend Junior	2023-09-18	Annually	3	0.15%
TALBROAUTO.NS	Dividend Junior	2023-09-15	Annually	18	0.48%
NGIL.NS	No Dividend Player	2023-09-21	Annually	4	0.08%
IGPL.NS	Dividend Junior	2023-08-17	Sporadic	18	1.12%
CHEMFAB.NS	Dividend Junior	2023-08-22	Sporadic	7	0.32%
SAKSOFT.NS	Dividend Junior	2023-08-07	Semi-Annually	20	0.56%
LUMAXIND.NS	Dividend Junior	2023-08-10	Annually	23	1.26%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.0222	1.500	-0.445	-0.667	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	-0.0145	1.500	-1.273	-1.909	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	2.63	1.000	-0.137	-0.137	[3 - 30]
operatingCashFlowPerShareTTM	12.22	2.00	5.93	10.00	[0 - 30]
freeCashFlowPerShareTTM	12.22	2.00	3.89	7.78	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.484	1.000	5.27	5.27	[0.2 - 0.8]
operatingProfitMarginTTM	-0.107	1.000	-4.14	-4.14	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				-0.101

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-69.66	1.000	-7.14	0	[1 - 100]
returnOnEquityTTM	-0.0145	2.50	-0.818	-1.909	[0.1 - 1.5]
freeCashFlowPerShareTTM	12.22	2.00	5.93	7.78	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	12.22	2.00	5.93	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.466	1.500	-6.44	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.136	1.000	9.11	0	[0.1 - 0.5]
Total Score				1.027

Panacea Biotec Limited

Panacea Biotec Limited, a biotechnology company, engages in the research and development, manufacture, and marketing of pharmaceuticals, vaccines, and biosimilars in India. It operates through Vaccines and Formulations segments. The company's product portfolio includes prescription products in various therapeutic areas, such as pain management, diabetes and cardiovascular management, oncology, renal disease management, osteoporosis management, anti-tubercular, and gastro-intestinal care; and vaccines for anthrax, dengue, Japanese encephalitis, and others. It also exports its products to over 30 countries worldwide, including the United States, Germany, the Russian Federation, Sri Lanka, the Philippines, etc. The company has a collaboration agreement with the Russian Direct Investment Fund for producing Covid-19 vaccine Sputnik-V; and the Coalition for Epidemic Preparedness Innovations and Translational Health Science and Technology Institute to develop vaccine candidates that could protect against SARS-Cov-2 variants and other Beta coronaviruses. Panacea Biotec Limited was incorporated in 1984 and is based in New Delhi, India.